24,225 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Purchased by Centiva Capital LP

Centiva Capital LP acquired a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 24,225 shares of the company’s stock, valued at approximately $1,608,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Hollencrest Capital Management purchased a new stake in shares of Ryan Specialty during the 3rd quarter valued at approximately $25,000. Assetmark Inc. purchased a new position in Ryan Specialty during the 3rd quarter valued at about $34,000. GAMMA Investing LLC increased its position in shares of Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after buying an additional 297 shares during the period. Crewe Advisors LLC purchased a new stake in shares of Ryan Specialty in the second quarter worth about $39,000. Finally, Rothschild Investment LLC bought a new position in shares of Ryan Specialty in the second quarter valued at approximately $87,000. Institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Bank of America upped their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Barclays boosted their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. UBS Group lifted their price target on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research report on Tuesday, August 13th. Finally, BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $71.67.

Ryan Specialty Price Performance

Shares of NYSE:RYAN opened at $74.26 on Wednesday. The stock has a market cap of $19.44 billion, a PE ratio of 96.44, a PEG ratio of 1.68 and a beta of 0.67. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.97. The company’s fifty day moving average is $70.43 and its 200 day moving average is $63.55. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company’s revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 EPS. Research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty’s dividend payout ratio is 57.14%.

Insider Buying and Selling at Ryan Specialty

In related news, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. The trade was a 8.28 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.